☰

Wei Huang

Affiliations: 
2013- School of Life Sciences, Xiamen University 
Google:
"Wei Huang"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Xianming DENG grad student 2013- School of Life Sciences, Xiamen University

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Su J, Zheng J, Huang W, et al. (2022) PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron. Signal Transduction and Targeted Therapy. 7: 167
Feng L, Chen K, Huang W, et al. (2022) Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma. Cell Death Discovery. 8: 39
Lu Y, Fan Z, Zhu SJ, et al. (2021) A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC. Embo Molecular Medicine. e14296
Wang Y, Zhang L, Wei Y, et al. (2020) Pharmacological Targeting of Vacuolar H-ATPase via Subunit V1G Combats Multidrug-Resistant Cancer. Cell Chemical Biology
Zhang L, Wang Y, Huang W, et al. (2020) Biosynthesis and Chemical Diversification of Verucopeptin Leads to Structural and Functional Versatility. Organic Letters
Zhang J, Bhuiyan MIH, Zhang T, et al. (2020) Modulation of brain cation-Cl cotransport via the SPAK kinase inhibitor ZT-1a. Nature Communications. 11: 78
Huang W, Sun X, Li Y, et al. (2018) Discovery and Identification of Small Molecules as Methuosis Inducers with In Vivo Antitumor Activities. Journal of Medicinal Chemistry
Deng J, Wang ES, Jenkins RW, et al. (2017) CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation. Cancer Discovery
Jiang H, He H, Chen Y, et al. (2017) Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. The Journal of Experimental Medicine
Jiang J, Gui F, He Z, et al. (2016) Targeting BRK-positive breast cancers with small molecule kinase inhibitors. Cancer Research
See more...